Posted August 18, 2021
DURHAM – Fast-growing Velocity Clinical is building up for more speed by adding senior executives to help lead the company’s planned expansion to Europe.
Velocity was recently acquired by European-based private equity firm Global Healthcare Opportunities (GHO). house.
The new execs include:
- Dominic Clavell, Executive Vice President, Europe
- Erin Williams, Vice President, Contracts and Regulatory
- Charles-Hubert Devaux, Senior Director, Patient Recruitment
“When US companies try to expand into Europe, they tend to do this remotely, attempting to manage operations from the States. We’re breaking the mould by putting boots on the ground,” said CEO G. Paul Evans.
“Velocity is carving out a new category of pharma services. The clinical trials site landscape will look very different in the next 12 months and Velocity is well placed to take advantage of this consolidation in the market.”
TO READ THE FULL STORY
Only B2BAmericanSoutheast.com members have access to curated Southeast news for technology, fintech, growth and exporting specifically for the 27 major cities in the regional states of Alabama, Florida, Georgia, Kentucky, Mississippi, North Carolina, South Carolina, and Tennessee. It’s about the executives and the decisions that result in the business activities that make the American Southeast the strong economic powerhouse – even stronger. Subscribe now!